Comerica Securities’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Comerica Securities’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,077	Closed	-$123K	–	1507
2022 Q4	$123K	Buy	+1,077	New	+$89.5K	0.01%	567
2022 Q2	–	Sell	-2,219	Closed	-$233K	–	519
2022 Q1	$233K	Sell	2,219 -50	-2%	-$4.87K	0.02%	449
2021 Q4	$245K	Buy	2,269 +84	+4%	+$9.16K	0.02%	453
2021 Q3	$239K	Buy	+2,185	New	+$227K	0.02%	457
2021 Q2	–	Sell	-4,514	Closed	-$415K	–	537
2021 Q1	$415K	Buy	4,514 +923	+26%	+$77.9K	0.03%	346
2020 Q4	$263K	Buy	3,591 +612	+21%	+$45.5K	0.02%	413
2020 Q3	$231K	Buy	+2,979	New	+$205K	0.02%	404

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Comerica Securities's HZNP Position: Q1 2023 in Review

Comerica Securities sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 1,077 shares — an estimated $123K sold.

Comerica Securities first reported a position in HZNP in Q3 2020 and held it in 7 quarters. The position peaked at $415K in Q1 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Comerica Securities reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 1,077 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $123K.
Comerica Securities first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 7 quarters.
Comerica Securities's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $415K in Q1 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.